Comparison of outcomes in high-risk prostate cancer patients treated with low-/high-dose-rate brachytherapy plus external beam radiotherapy
Yu Imai(Jikei University School of Medicine), Takahiro Kimura(Jikei University School of Medicine), Kosuke Iwatani(Jikei University School of Medicine), Manabu Aoki(Jikei University School of Medicine), Kojiro Tashiro(Jikei University School of Medicine), Mariko Honda(Jikei University School of Medicine), Kenta Miki(Jikei University School of Medicine), Minoru Nakazono(Jikei University School of Medicine), Shun Sato(Jikei University School of Medicine), Hiroyuki Takahashi(Jikei University School of Medicine), Fumihiko Urabe(Jikei University School of Medicine)
Cited by 7
Related Papers
Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study
|The Lancet Oncology|2020|631
Extracellular vesicles as biomarkers and therapeutic targets for cancer
|American Journal of Physiology-Cell Physiology|2019|412
Circulating miRNA panels for specific and early detection in bladder cancer
|Cancer Science|2018|282
Large-scale Circulating microRNA Profiling for the Liquid Biopsy of Prostate Cancer
|Clinical Cancer Research|2019|129
Exploiting the message from cancer: the diagnostic value of extracellular vesicles for clinical applications
|Experimental & Molecular Medicine|2019|112